| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-444 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
| filingDate |
2009-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_669e522e45e172af54294155607e937d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6595f8d45532a1f5c3e965578de1a404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16e61c4563e56032c9e73dff828f690
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3860136298c999da308127bc08ba1b63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75155ae4690d59ba0297c15d1c99bda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab58ae778ece6d2caaeacfc51b8e7281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a84fda6d0d306a7b970478f9d29a4c7 |
| publicationDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2383496-T3 |
| titleOfInvention |
Pegylated lispro insulin compounds |
| abstract |
A PEGylated lispro insulin compound of the formula: P - [(A) - (B)], or a pharmaceutically acceptable salt thereof, wherein: A is the insulin chain lispro A and has the amino acid sequence of SEC ID No. 1; B is the B chain of insulin lispro and has the amino acid sequence of SEQ ID No. 3; and P is a PEG having a molecular weight in the range of about 17.5 kDa to about 40 kDa, and in which A and B are properly crosslinked and P is directly linked by a covalent urethane bond to the lysine epsilon-amino group in position 28 of chain B. |
| priorityDate |
2008-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |